Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes” (J Clin Endo Metab Case Reports. 2023; 1(1): 10.1210/jcemcr/luac017)

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578365/
https://www.ncbi.nlm.nih.gov/pubmed/37908263
http://dx.doi.org/10.1210/jcemcr/luad005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578365/
https://www.ncbi.nlm.nih.gov/pubmed/37908263
http://dx.doi.org/10.1210/jcemcr/luad005

Ejemplares similares